CEPR’s Dr. Karen Kopciuk, together with Dr Huiming Yang and their colleagues, were recently awarded a Strategic Clinical Network (SCN) seed grant entitled: Test of cure: Use of Human Papillomavirus (HPV) testing to optimize the cervical cancer screening clinical pathway post-treatment.
This grant was one of four grants recently awarded by the SCN for which there was a 12.5% success rate, hence, a great achievement for Dr. Kopciuk and her team.